Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reexamination ...
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The agreements come on the heels of a string of successes in the reexamination of the MMP Portfolio™ patents by the USPTO and German Patent Court. In the past 9 months, the German Patent Court affirmed the validity of EP’730, and the USPTO has affirmed the validity of both US’584 and most recently US’336.

http://www.alliacense.com/Press_Release_Details.aspx?PressID=117

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply